Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
作者信息
Batchelor Wayne B, Damluji Abdulla A
机构信息
Inova Schar Heart and Vascular, Falls Church, Virginia, USA.
Inova Schar Heart and Vascular, Falls Church, Virginia, USA.
出版信息
J Am Coll Cardiol. 2024 Mar 19;83(11):1082-1084. doi: 10.1016/j.jacc.2024.01.028.
Abstract
摘要
相似文献
1
Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
J Am Coll Cardiol. 2024 Mar 19;83(11):1082-1084. doi: 10.1016/j.jacc.2024.01.028.
2
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
3
Myocardial Revascularization in Patients With 3 Vessel Coronary Artery Disease and Chronic Kidney Disease: Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention.
Am J Cardiol. 2025 May 15;243:8-14. doi: 10.1016/j.amjcard.2025.02.004. Epub 2025 Feb 7.
4
Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
JAMA. 2013 Nov 20;310(19):2086-95. doi: 10.1001/jama.2013.281718.
5
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With and Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
Circulation. 2024 Apr 23;149(17):1328-1338. doi: 10.1161/CIRCULATIONAHA.123.065571. Epub 2024 Mar 11.
6
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Eur Heart J. 2014 Oct 21;35(40):2821-30. doi: 10.1093/eurheartj/ehu213. Epub 2014 May 21.
7
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
J Am Coll Cardiol. 2018 Aug 14;72(7):754-765. doi: 10.1016/j.jacc.2018.05.057.
8
Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.
Eur J Cardiothorac Surg. 2014 Mar;45(3):431-7. doi: 10.1093/ejcts/ezt429. Epub 2013 Aug 26.
9
Readmission rate after coronary artery bypass grafting versus percutaneous coronary intervention for unprotected left main coronary artery narrowing.
Am J Cardiol. 2014 May 15;113(10):1639-46. doi: 10.1016/j.amjcard.2014.02.013. Epub 2014 Mar 1.
10
[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005.
本文引用的文献
1
The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future Challenges.
JACC Adv. 2023 Jan 11;2(1):100160. doi: 10.1016/j.jacadv.2022.100160. eCollection 2023 Jan.
2
Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.
J Am Coll Cardiol. 2024 Mar 19;83(11):1073-1081. doi: 10.1016/j.jacc.2024.01.012.
3
Effects of a Multimodal Transitional Care Intervention in Patients at High Risk of Readmission: The TARGET-READ Randomized Clinical Trial.
JAMA Intern Med. 2023 Jul 1;183(7):658-668. doi: 10.1001/jamainternmed.2023.0791.
4
Five-Year Hospital Readmission After Coronary Artery Bypass Surgery and the Association With Off-Pump Surgery and Sex.
J Am Heart Assoc. 2023 Apr 18;12(8):e028063. doi: 10.1161/JAHA.122.028063. Epub 2023 Apr 7.
5
In search of the "IDEAL" left main coronary stent and DAPT regimen.
EuroIntervention. 2022 Apr 22;17(18):1457-1459. doi: 10.4244/EIJ-E-22-00006.
6
The Influence of Frailty on Cardiovascular Disease: The Time for a "Frailty Academic Research Consortium" Is Now!
Circ Cardiovasc Interv. 2022 Jan;15(1):e011669. doi: 10.1161/CIRCINTERVENTIONS.121.011669. Epub 2022 Jan 18.
7
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
J Am Coll Cardiol. 2022 Jan 18;79(2):e21-e129. doi: 10.1016/j.jacc.2021.09.006. Epub 2021 Dec 9.
8
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
Lancet. 2021 Dec 18;398(10318):2247-2257. doi: 10.1016/S0140-6736(21)02334-5. Epub 2021 Nov 15.
9
Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2020 Dec 1;76(22):2650-2670. doi: 10.1016/j.jacc.2020.09.606.
10
Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Insights From a Network Meta-Analysis of Randomized Trials.
Cardiovasc Revasc Med. 2021 Jul;28:50-56. doi: 10.1016/j.carrev.2020.07.039. Epub 2020 Aug 1.
Zotero 插件